Large studies showed that neurogranin levels in CSF specifically increased in AD compared to several other neurodegenerative diseases, including PD, FTD, ALS, and vascular dementia [157,158], confirming the potential of CSF neurogranin in separating AD dementia from non-AD dementia. The gene discussed is NRGN; the disease is frontotemporal dementia.